Skip to main content

Advertisement

Log in

Report of two Cases with Metastasis in Lymph NodesAlong the Posterior Leaf of the Bursa Omentalis at the Area of the Pancreatic Body, an Area not Routinely Examined in Standard Gastrectomy Plus Bursectomy for Advanced Gastric Cancer

  • Case Report
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Han KB, Jang YJ, Kim JH, Park SS, Park SH, Kim SJ, et al. Clinical significance of the pattern of lymph node metastasis depending on the location of gastric cancer. J Gastric Cancer. 2011;11:86–93.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines (ver. 3). Gastric Cancer. 2011;14:113–23.

    Article  Google Scholar 

  3. Eom BW, Joo J, Kim YW, Reim D, Park JY, Yoon HM, et al. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer. Surgery. 2013;155:408–16.

    Article  PubMed  Google Scholar 

  4. Blouhos K, Boulas KA, Tsalis K, Hatzigeorgiadis A (2015) Right-sided bursectomy as an access plane for aesthetic resection of the posterior leaf of the lesser sac from the head of the pancreas en-block with the No. 6 and 14v lymph nodes in advanced lower-third gastric cancer. Surgery [Epub ahead of print]

  5. Blouhos K, Boulas KA, Hatzigeorgiadis A. Metastasis in lymph nodes on the anterior pancreatic surface of the body and tail: an extremely rare finding during bursectomy in extended surgery for gastric cancer. Updat Surg. 2015;67:97–8.

    Article  Google Scholar 

  6. Blouhos K, Boulas KA, Hatzigeorgiadis A. Making omental bursectomy, a routine in extended gastrectomy; a step-by-step guide. Hell J Surg. 2013;85:269–73.

    Article  Google Scholar 

  7. Blouhos K, Boulas KA, Hatzigeorgiadis A. Bursectomy in gastric cancer surgery: surgical technique and operative safety. Updat Surg. 2013;65:95–101.

    Article  Google Scholar 

  8. Blouhos K, Tsalis K, Boulas KA, Hatzigeorgiadis. Bursectomy in Gastric Cancer Surgery. In: Bhullar JS, editor. Gastric cancer: risk factors, treatment and clinical outcomes. 1st ed. Michigan: Nova Science; 2014. p. 209–19.

    Google Scholar 

  9. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.

    Article  Google Scholar 

  10. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging manual. Cancer. 2003;98:2740–1.

    Article  PubMed  Google Scholar 

  11. Hartgritik HH, van de Velde CJ, Putter H, Bonenkamp JJ, Kranenbarg HKE, Songun I, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group Trial. J Clin Oncol. 2004;22:2069–77.

    Article  Google Scholar 

  12. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D1 and D2 dissections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999;79:1522–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Songun I, Putter H, Kranenbarg EMK, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.

    Article  PubMed  Google Scholar 

  14. Chen R, Wang H, Wang M, Guan W. Analysis of risk factors associated with metastasis of lymph node along superior mesenteric vein in patients with gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 2014;17:155–7.

    CAS  PubMed  Google Scholar 

  15. An JY, Pak KH, Inaba K, Cheong JH, Hyung WJ, Noh SH. Relevance of lymph node metastasis along the superior mesenteric vein in gastric cancer. Br J Surg. 2011;98:667–72.

    Article  CAS  PubMed  Google Scholar 

  16. Masuda TA, Sakaguchi Y, Toh Y, Aoki Y, Harimoto N, Taomoto J, et al. Clinical characteristics of gastric cancer with metastasis to the lymph node along the superior mesenteric vein (14v). Dig Surg. 2008;25:351–8.

    Article  PubMed  Google Scholar 

  17. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359:453–62.

    Article  CAS  PubMed  Google Scholar 

  18. Zhang C, He Y, Schwarz RE, Smith DD, Wang L, Liu F, et al. Evaluation of para-aortic nodal dissection for locoregionally advanced gastric cancer with 1–3 involved para-aortic nodes. Chin Med J (Engl). 2014;127:435–41.

    Google Scholar 

  19. Kodera Y, Kobayashi D, Tanaka C, Fujiwara M (2014) Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer? Surg Today. [Epub ahead of print]

  20. Diaz-Nieto R, Orti-Rodríguez R, Winslet M. Post-surgical chemotherapy versus surgery alone for resectable gastric cancer. Cochrane Database Syst Rev. 2013;2(9):CD008415.

    Google Scholar 

  21. Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Stomach Cancer Study Group of the Japan Clinical Oncology Group, et al. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101:653–60.

    Article  CAS  PubMed  Google Scholar 

  22. Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29:1715–21.

    Article  CAS  PubMed  Google Scholar 

  23. Wu AW, Xu GW, Wang HY, Ji JF. WITHDRAWN: neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Database Syst Rev. 2007;17:CD005047.

    Google Scholar 

  24. Xiong B, Ma L, Cheng Y, Zhang C. Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: an updated meta-analysis of randomized controlled trials. Eur J Surg Oncol. 2014;40:1321–30.

    Article  CAS  PubMed  Google Scholar 

  25. Wang Y, Yu YY, Li W, Feng Y, Hou J, Ji Y, et al. A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemother Pharmacol. 2014;73:1155–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Katayama H, Ito S, Sano T, Takahari D, Mizusawa J, Boku N, et al. A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002. Jpn J Clin Oncol. 2012;42:556–9.

    Article  PubMed  Google Scholar 

Download references

Informed Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images.

Conflict of interest

None

Funding

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Konstantinos A. Boulas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Blouhos, K., Boulas, K.A., Tsalis, K. et al. Report of two Cases with Metastasis in Lymph NodesAlong the Posterior Leaf of the Bursa Omentalis at the Area of the Pancreatic Body, an Area not Routinely Examined in Standard Gastrectomy Plus Bursectomy for Advanced Gastric Cancer. J Gastrointest Canc 47, 436–441 (2016). https://doi.org/10.1007/s12029-015-9756-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-015-9756-6

Keywords

Navigation